Correction: Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
BMJ Publishing Group
2021-10-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/9/10/e003521corr1.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CXCL10 promotes melanoma angiogenesis and tumor growth
by: Bongjun Kim, et al.
Published: (2024-12-01) -
The Crosstalk with CXCL10‐Rich Tumor‐Associated Mast Cells Fuels Pancreatic Cancer Progression and Immune Escape
by: Hanlin Yin, et al.
Published: (2025-04-01) -
Immunometabolism signature derived from on-treatment tumor specimens predicts immune checkpoint blockade response in metastatic melanoma
by: Shuzhao Chen, et al.
Published: (2025-07-01) -
Biomarker Significance of Serum CXCL8, CXCL10 and CXCL16 in Breast Tumors of Iraqi Patients
by: Aseel F Khalaf, et al.
Published: (2020-03-01) -
Adipocyte-derived CXCL10 in obesity promotes the migration and invasion of ovarian cancer cells
by: Zhe Wang, et al.
Published: (2024-12-01)